GO Therapeutics, with headquarters in Cambridge, Mass., signed a licensing deal with Swiss-based Roche to develop antibodies for cancer.
Three Small CRISPR Biotechs That Could Cure 10,000 Diseases
Blood Diseases, Cancer, Collaborations, CRISPR/Cas9, Diseases, DNA, Eye Diseases, FDA, Gene Editing, Genetic Disorders, Genomics, Hematopoietic Stem Cells, Herpes Simplex Virus, Hunter Syndrome, Immune Cells, Inflammatory Disorders, J.P. Morgan Healthcare Conference, Liver Disease, Lung Disease, Muscle Disease, R&D, Sickle Cell Disease, Thalassemia, Transthyretin (TTR) Amyloidosis, Viral Infections, World Health OrganizationInvestor’s Business Daily looked at three small biotech companies that appear to be leading the CRISPR race.
